PTC
ELV icon

Philadelphia Trust Company’s Elevance Health ELV Stock Holding History

Philadelphia Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-512
Closed -$235K – 233
2023
Q1 		$235K Hold
512
– – 0.02% 204
2022
Q4 		$263K Hold
512
– – 0.03% 193
2022
Q3 		$233K Hold
512
– – 0.03% 190
2022
Q2 		$247K Hold
512
– – 0.03% 188
2022
Q1 		$252K Buy
+512
New +$234K 0.02% 205

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Philadelphia Trust Company's ELV Position: Q2 2023 in Review

Philadelphia Trust Company sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 512 shares — an estimated $235K sold.

Philadelphia Trust Company first reported a position in ELV in Q1 2022 and held it in 5 quarters. The position peaked at $263K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Philadelphia Trust Company reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Philadelphia Trust Company sold 512 Elevance Health shares in Q2 2023, an estimated $235K.
  • Philadelphia Trust Company first reported a position in Elevance Health in Q1 2022 and held it in 5 quarters.
  • Philadelphia Trust Company's Elevance Health position peaked at $263K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Philadelphia Trust Company's 13F filing for Q2 2023, filed 7 Aug 2023.